LoCHAid: An ultra-low-cost hearing aid for age-related hearing loss.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 21 02 2020
accepted: 26 08 2020
entrez: 23 9 2020
pubmed: 24 9 2020
medline: 30 10 2020
Statut: epublish

Résumé

Hearing aids are the primary tool in non-medical rehabilitation for individuals with hearing loss. While the costs of the electronic components have reduced substantially, the cost of a hearing aid has risen steadily to the point that it has become unaffordable for the majority of the population with Age-Related Hearing Loss (ARHL) especially for those residing in low- and middle-income countries. Here, we present an ultra-low-cost, affordable and accessible hearing aid device ('LoCHAid'), specifically targeted towards treating ARHL in elderly patients. The LoCHAid components cost 98 cents (< $1) when purchased in bulk for 10,000 units and can be personalized for each user through a 3D-printable case. It is designed to be an over-the-counter (OTC) self-serviceable solution for elderly individuals with ARHL. Electroacoustic measurements show that the device meets most of the targets set out by the WHO Preferred Product Profile and Consumer Technology Association for hearing aids. The frequency response of the hearing aid shows selectable gain in the range of 4-8 kHz, and mild to moderate gain between 200-1000 Hz, and shows very limited total distortion (1%). Simulated gain measurements show that the LoCHAid is well fitted to a range of ARHL profiles for males and females between the ages of 60-79 years. Overall, the measurements show that the device offers the potential to benefit individuals with ARHL. Thus, our proposed design has the potential to address the challenge of affordable and accessible hearing technology for hearing impaired elderly individuals especially in low- and middle-income countries.

Identifiants

pubmed: 32966301
doi: 10.1371/journal.pone.0238922
pii: PONE-D-20-05119
pmc: PMC7510997
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0238922

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Trends Amplif. 2011 Dec;15(4):209-14
pubmed: 22068223
Lancet. 2002 Oct 26;360(9342):1333-4
pubmed: 12414236
Disabil Rehabil. 2005 Jun 3;27(11):601-9
pubmed: 16019870
Am J Audiol. 2012 Dec;21(2):175-80
pubmed: 22846638
Biomed Res Int. 2015;2015:827463
pubmed: 26557701
J Am Acad Audiol. 2016 Sep;27(8):619-27
pubmed: 27564440
J Neurosci. 2006 Feb 15;26(7):2115-23
pubmed: 16481444
Ear Hear. 2007 Apr;28(2):187-95
pubmed: 17496670
Am J Public Health. 2016 Jun;106(6):1032-5
pubmed: 27077339
J Speech Lang Hear Res. 2008 Feb;51(1):160-72
pubmed: 18230863
Trends Amplif. 2010 Sep;14(3):127-54
pubmed: 21109549
Trends Amplif. 2010 Jun;14(2):64-72
pubmed: 20724354
J Acoust Soc Am. 2010 Apr;127(4):2521-8
pubmed: 20370034
Semin Hear. 2018 May;39(2):135-145
pubmed: 29915451
Int J Audiol. 2004 May;43(5):295-306
pubmed: 15357413
Am J Epidemiol. 1998 Nov 1;148(9):879-86
pubmed: 9801018
J Am Acad Audiol. 2008 Oct;19(9):672-85
pubmed: 19418707
Clin Interv Aging. 2017 May 18;12:859-871
pubmed: 28553093
Int J Audiol. 2013 May;52(5):360-8
pubmed: 23473329
PLoS One. 2014 Jun 18;9(6):e98781
pubmed: 24940755
Trends Amplif. 2010 Jun;14(2):63
pubmed: 20724353
Disabil Rehabil Assist Technol. 2014 Sep;9(5):360-4
pubmed: 24702607
Audiology. 2000 Mar-Apr;39(2):110-6
pubmed: 10882051
J Am Acad Audiol. 2007 Sep;18(8):653-64
pubmed: 18326152
JAMA. 2017 Jul 4;318(1):89-90
pubmed: 28672306
Int J Audiol. 2010 Dec;49(12):891-903
pubmed: 21070124
JAMA. 2016 Aug 23-30;316(8):819-20
pubmed: 27254725

Auteurs

Soham Sinha (S)

School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, United States of America.

Urvaksh D Irani (UD)

School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, United States of America.

Vinaya Manchaiah (V)

Department of Speech and Hearing Sciences, Lamar University, Beaumont, TX, United States of America.

M Saad Bhamla (MS)

School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH